Ultragenyx Pharmaceutical INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersNovato, CA
SAM.gov UEIMS1ZFMTA7JH7
Brands
This company sells these brands.
Ultragenyx develops therapies for rare and ultrarare genetic diseases using various drug modalities, including a gene therapy platform. The company's pipeline includes treatments for specific genetic conditions such as glycogen storage disease type Ia, ornithine transcarbamylase deficiency, Wilson disease, osteogenesis imperfecta, Angelman syndrome, mucopolysaccharidosis IIIA, and other rare genetic disorders.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | Novato | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.